Featured Education

Playlist

3 Videos

On Demand Activities

More results...

Therapeutics Areas
Learner Specialties
Expires After
  • On-Demand
Weight Management as a Treatment for T2D: Novel Pharmacological Approaches
  • Credit: 0.50hr(s)
  • AAFP, AAPA, ABIM, CME, IPCE, MOC
  • April 30, 2024 — 
  • October 31, 2025
  • Therapeutic Areas: Diabetes, Family Medicine / Primary Care, Obesity
  • Specialties: Diabetes, Endocrinology, Obesity, Primary Care
  • Location: Internet Activity Enduring
Healthcare providers (HCPs) encounter significant challenges when treating patients with type 2 diabetes (T2D). HCPs should be cognizant of when to change or intensify treatment and be aware of options that are non-optimal. As such, HCPs need to be equipped with current professional guidelines, the latest clinical evidence on new and emerging therapies for T2D, and strategies for engaging patients in shared decision-making to effectively prioritize weight management and promote comprehensive T2D care.
Access Course
  • On-Demand
Enhancing Patient Care for CAR T-Cell Therapy in NHL: Comprehensive Solutions for Your Community
  • Credit: 1.0hr(s)
  • ABIM, CME, IPCE, MOC, NCPD, Royal College MOC 
  • June 15, 2024 — 
  • June 14, 2025
  • Therapeutic Areas: Chronic Lympoblastic Leukemia (CLL)
  • Specialties: Mantle Cell Lymphoma
  • Location: Internet Activity Enduring
In this Build Your Own Case Study | Enhancing Patient Care for CAR T-Cell Therapy in NHL: Comprehensive Solutions for Your Community, learn from expert faculty about the most recent clinical updates and emerging real-world efficacy and safety data of CAR T-cell therapies in NHL. Build Your Own Case Study will guide participants through an interactive learning progression, as they go through two patient scenarios and make selections at critical decision points. Participants will be provided with patient clinical presentation and other relevant factors including age, time and aggressiveness of relapse, social history, genetic profiling/molecular testing results, cytogenetic risk factors, disease subtype, comorbidities, and prior therapies in order to make appropriate treatment decisions. Expert faculty will discuss participant selection of treatments, sequencing considerations, and drug-related toxicities. The activity will conclude with a discussion on how to develop strategies to assist patients with coordinated care and long-term disease management after the receipt of CAR T-cell therapy. This ancillary educational activity is derived from the 2024 ASCO Annual Meeting, originally held on May 31, 2024
Access Course
  • On-Demand
Improving Survival in First-Line Metastatic NSCLC with Dual Checkpoint Blockade: Exploring Recent Data and Treatment Strategies / Activity 1
  • Credit: 0.50hr(s)
  • AAPA, CME, CPE, NCPD
  • February 17, 2023 — 
  • September 30, 2024
  • Therapeutic Areas: Hematologic Oncology, Oncology
  • Specialties: NSCLC, Oncology
  • Location: Internet Activity Enduring
This educational initiative is designed for community-based oncology clinicians (physicians, nurse practitioners [NPs], physician assistants [PAs], pharmacists, and nurses) to enhance outcomes for individuals with who provide care for individuals with mNSCLC. This interactive online activity uses the game-based platform Kahoot! to test participant ability to identify and apply key learning points while competing against their colleagues. Expert faculty will discuss the emerging efficacy and safety data for CTLA-4 inhibitor combination regimens in metastatic NSCLC (mNSCLC) and explore strategies to identify patients who would most benefit from these therapies through the use of biomarkers. Additionally, there will be an in-depth discussion regarding approaches to effectively collaborate with other clinicians and mNSCLC patients to provide cost-effective, equitable, and inclusive care for patients of all socioeconomic and racial/ethnic backgrounds. Join us for Part 2 of this question and answer based educational activity, Improving Survival in First-line Metastatic NSCLC with Dual Checkpoint Blockade: Real-world Applications in Clinical Practice to apply the evidence to real-world patient cases!
Access Course
  • On-Demand
Supporting the Family Caregiver
  • Credit: 0.50hr(s)
  • CME
  • September 16, 2024 — 
  • September 15, 2025
  • Therapeutic Areas: Oncology
  • Specialties: Breast Cancer
  • Location: Internet Activity Enduring
The role of the treatment team in supporting the family caregiver. What you will learn from this module: Learn the physical and emotional needs of the caregiver managing the patient at home. Understand the stress and challenges loved ones face while caregiving. Realize that oftentimes the oncologist’s focus is solely on the patient and not on the loved one who is caregiving. Understand that a caregiver for a patient might be someone outside of the family- like a close friend. This can be due to the lack of family members, dysfunctional family dynamics, or ages of family members (young and old).
Access Course
  • On-Demand
Overcoming Obesity: A PCP's Guide to Comprehensive Obesity Care
  • Credit: 1.50hr(s)
  • AAPA, ABIM, CME, MOC, NCPD
  • September 1, 2024 — 
  • August 31, 2025
  • Specialties: Primary Care
  • Location: Internet Activity Enduring
Addressing obesity in primary care remains a significant challenge, despite established evidence-based strategies and the introduction of new anti-obesity medications. Obstacles such as weight bias, stigma, and limited patient engagement in shared decision-making complicate effective weight management. With the growing array of therapeutic options for obesity, it is crucial for clinicians to adopt shared decision-making practices to improve treatment adherence, support patient goals, and foster holistic, patient-centered care. Join our engaging 3-part on-demand Community Collective Chapter Series, Overcoming Obesity: A PCP’s Guide to Comprehensive Obesity Care. This series, in collaboration with local AAFP Chapter meetings, equips learners with evidence-based approaches to screening, diagnosing, and treating obesity. Gain practical strategies for initiating weight management conversations with patients, incorporating shared decision-making to personalize treatment goals. Don’t miss this opportunity! Enroll now to gain valuable insights and elevate your practice in obesity care.
Access Course
  • On-Demand
Transforming Relapsed/Refractory MCL: Exploring New Options for Your Patients
  • Credit: 1.0hr(s)
  • CME, EBAH, ECMEC
  • June 28, 2023 — 
  • June 28, 2024
  • Therapeutic Areas: Hematologic Oncology, Hematology, Oncology
  • Specialties: Lymphoma, Mantle Cell Lymphoma
  • Location: Internet Activity Enduring
Treatment for R/R MCL is complicated, as the disease typically presents in elderly, unfit patients; however, emerging targeted therapy options have shown great promise based on excellent results in clinical trials. In this activity, a taped version of the live symposium at the 17th Annual International Conference on Malignant Lymphoma, expert faculty present therapeutic options, established by evidence-based practice guidelines, for patients with R/R MCL. Symposium learners voted on patient demographics and parameters such as treatment, dosing frequency, and adverse events. The experts crafted their lecture to follow thheir suggestions allowing the case studies to reflect the patients the learners see. The activity concludes with a discussion on engagement between healthcare providers and patients to improve clinical outcomes.
Access Course
View All MLI Activities
Facebook Twitter Linkedin Instagram
Subscribe to Mailing List
Scroll to Top